amitriptyline has been researched along with Cancer of Head in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients treated for head and neck cancer are chronic opioid users to manage their post-treatment pain, which may entail an increased risk of addiction and overdose." | 3.11 | Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae. ( Boden, A; Bourgouin, M; Caunes-Hilary, N; Fabre, A; Filleron, T; Lodin, S; Lusque, A; Mauries, V; Moreau, C; Mounier, M; Poublanc, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boden, A | 2 |
| Lusque, A | 2 |
| Lodin, S | 2 |
| Bourgouin, M | 2 |
| Mauries, V | 2 |
| Moreau, C | 2 |
| Fabre, A | 2 |
| Mounier, M | 2 |
| Poublanc, M | 2 |
| Caunes-Hilary, N | 2 |
| Filleron, T | 2 |
| Steel, SJ | 1 |
| Robertson, CE | 1 |
1 review available for amitriptyline and Cancer of Head
| Article | Year |
|---|---|
First Bite Syndrome: What Neurologists Need to Know.
Topics: Acetylcholine Release Inhibitors; Amitriptyline; Analgesics, Non-Narcotic; Botulinum Toxins; Carotid | 2021 |
1 trial available for amitriptyline and Cancer of Head